Home
Scholarly Works
IMPROVED 6-MONTH SURVIVAL RATE IN SUBJECTS WITH...
Conference

IMPROVED 6-MONTH SURVIVAL RATE IN SUBJECTS WITH PROSTATE STEM CELL ANTIGEN POSITIVE TUMORS IN A GLOBAL, RANDOMIZED PHASE 2 TRIAL COMPARING GEMCITABINE VS. GEMCITABINE + AGS-1C4D4 (ASP6182) IN METASTATIC PANCREATIC CANCER

Authors

Hidalgo M; O'Reilly EM; Ko YJ; Blaszkowksy LS; Rarick MU; Lima CMSR; Ritch PS; Chan E; Spratlin JL; Macarulla T

Volume

22

Pagination

pp. v12-v12

Publisher

OXFORD UNIV PRESS

Publication Date

June 1, 2011

Name of conference

European-Society-for-Medical-Oncology (ESMO) 13th World Congress on Gastrointestinal Cancer

Conference place

Barcelona, SPAIN

Conference start date

June 22, 2011

Conference end date

June 25, 2011

Conference proceedings

ANNALS OF ONCOLOGY

ISSN

0923-7534

Contact the Experts team